Loading…

High Cell Density Cultivation Process for the Expression of Botulinum Neurotoxin a Receptor Binding Domain

The receptor-binding domain of botulinum neurotoxin (H fragment), is a promising botulism vaccine candidate. In the current study, fermentation strategies were evaluated to upscale H fragment expression. A simple translation of the growth conditions from shake flasks to a batch fermentation process...

Full description

Saved in:
Bibliographic Details
Published in:Toxins 2022-04, Vol.14 (4), p.281
Main Authors: Ben David, Alon, Papir, Yoel, Hazan, Ophir, Redelman, Moses, Diamant, Eran, Barnea, Ada, Torgeman, Amram, Zichel, Ran
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The receptor-binding domain of botulinum neurotoxin (H fragment), is a promising botulism vaccine candidate. In the current study, fermentation strategies were evaluated to upscale H fragment expression. A simple translation of the growth conditions from shake flasks to a batch fermentation process resulted in limited culture growth and protein expression (OD of 11 and volumetric protein yields of 123 mg/L). Conducting fed-batch fermentation with rich media and continuous nutrient supplementation significantly improved culture growth (OD of 40.3) and protein expression (1093 mg/L). A further increase in H fragment yield was achieved by high cell density cultivation (HCDC). The bacterium was grown in a defined medium and with a combined bolus/continuous feed of nutrients to maintain desired oxygen levels and prevent acetate accumulation. The final OD of the process was 260, and the volumetric yield of the H fragment was 2065 mg/L, which reflects improvement by an order of magnitude. Purified H fragments, produced by HCDC, exhibited typical biochemical and protective characteristics in mice. Taken together, the advancements achieved in this study promote large-scale production of the H fragment in for use in anti-botulism vaccines.
ISSN:2072-6651
2072-6651
DOI:10.3390/toxins14040281